In the future, continued data collection and analysis will be based on glioblastoma definition according to the most recent fifth edition of the WHO classification released in 2021, which also includes the concept of molecular glioblastoma, and does not include high-grade IDH-mutant astrocytic gliomas anymore [19]. The gene discussed is IDH1; the disease is glioblastoma.